Nebenwirkungen · NovoRapid
NovoRapid 100 units/ml solution for injection in vial NovoRapid Penfill 100 units/ml solution for injection in cartridge NovoRapid FlexPen 100 units/ml solution for injection in pre-filled pen NovoRapid InnoLet 100 units/ml solution for injection in pre-filled pen NovoRapid FlexTouch 100 units/ml solution for injection in pre-filled pen NovoRapid PumpCart 100 units/ml solution for injection in cartridge · Abschnitt 4.8 · PDF-Seite 9
HOS-090232 · Präparat HOS-084033
Based on post-marketing sources and clinical trials, the frequency, type and severity of adverse reactions observed in the paediatric population do not indicate any differences to the broader experience in the general population.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-05-28T02:00:00Z · SHA-256 596b72a285a1a6a53ef22a3d8e8f5b78afcad8d6266d30dcb5e7e2429eede7f2 · Passage bb6262c955a82ed3d7e4a7adc0089687b92943d9dbfa8fb650c37b46253eff31 · Zeichen 3938–4167 im Abschnitt